When stimulated with CXCL13, CLL B cells commit to actin polymerization, CXCR5 endocytosis, and the activation of p44/p42 mitogen-activated protein kinase (MAPK) [143]. Here, CXCR5 is linked to B-cell chronic lymphocytic leukemia.